Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Clemizole Hydrochloride Is a Novel and Potent Inhibitor of Transient Receptor Potential Channel TRPC5

Julia M. Richter, Michael Schaefer and Kerstin Hill
Molecular Pharmacology November 2014, 86 (5) 514-521; DOI: https://doi.org/10.1124/mol.114.093229
Julia M. Richter
Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Schaefer
Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerstin Hill
Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 86 no. 5 514-521
DOI 
https://doi.org/10.1124/mol.114.093229
PubMed 
25140002

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received April 13, 2014
  • Accepted August 19, 2014
  • Published online September 25, 2014.

Article Versions

  • Earlier version (August 19, 2014 - 10:14).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2014 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Julia M. Richter,
  2. Michael Schaefer, and
  3. Kerstin Hill
  1. Rudolf-Boehm-Institute of Pharmacology and Toxicology, University of Leipzig, Leipzig, Germany
  1. Address correspondence to:
    Dr. Kerstin Hill, Institute of Pharmacology and Toxicology, Härtelstr. 16-18, 04107 Leipzig, Germany. E-mail: kerstin.hill{at}medizin.uni-leipzig.de
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2014 to July 2022

AbstractFullPdf
Aug 2014144093
Sep 20142324133
Oct 20143604157
Nov 20141233240
Dec 2014531418
Jan 2015683838
Feb 2015351011
Mar 2015341621
Apr 2015261919
May 2015211820
Jun 2015211715
Jul 2015332215
Aug 2015411815
Sep 2015241615
Oct 2015194225
Nov 2015293431
Dec 201513208
Jan 2016203220
Feb 2016124127
Mar 2016164835
Apr 2016153424
May 2016102832
Jun 2016203330
Jul 201692718
Aug 2016243944
Sep 2016113845
Oct 201652920
Nov 201696020
Dec 201616326
Jan 201704819
Feb 201725313
Mar 201733923
Apr 201726126
May 201724715
Jun 201752822
Jul 2017333726
Aug 2017283020
Sep 2017315028
Oct 2017182312
Nov 2017425826
Dec 2017364254
Jan 2018484374
Feb 2018565344
Mar 2018648729
Apr 20187710567
May 20187310053
Jun 2018678055
Jul 2018355253
Aug 2018645748
Sep 2018685149
Oct 2018717379
Nov 2018354148
Dec 201833526
Jan 201921026
Feb 201931617
Mar 201932934
Apr 201944425
May 201922424
Jun 201912719
Jul 201922032
Aug 201941826
Sep 2019122128
Oct 201964414
Nov 20193746
Dec 2019101110
Jan 202012817
Feb 202011711
Mar 202021714
Apr 202042419
May 202041610
Jun 202032218
Jul 202062711
Aug 202021110
Sep 202081725
Oct 20204854
Nov 20204925
Dec 20204047
Jan 20215737
Feb 202148139
Mar 20217824
Apr 20213351
May 20216133
Jun 20212943
Jul 20211628
Aug 20214785
Sep 20212252
Oct 20213252
Nov 20213444
Dec 20213269
Jan 20222843
Feb 20221775
Mar 20224157
Apr 20229056
May 20224437
Jun 20223226
Jul 20221200

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 86 (5)
Molecular Pharmacology
Vol. 86, Issue 5
1 Nov 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Clemizole Hydrochloride Is a Novel and Potent Inhibitor of Transient Receptor Potential Channel TRPC5
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Clemizole Inhibits TRPC5 Channel Activity

Julia M. Richter, Michael Schaefer and Kerstin Hill
Molecular Pharmacology November 1, 2014, 86 (5) 514-521; DOI: https://doi.org/10.1124/mol.114.093229

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Clemizole Inhibits TRPC5 Channel Activity

Julia M. Richter, Michael Schaefer and Kerstin Hill
Molecular Pharmacology November 1, 2014, 86 (5) 514-521; DOI: https://doi.org/10.1124/mol.114.093229
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Michaelis Menten quantification of GPCR-G protein signalling
  • Human mAb 3F1 targeting the fuctional epitopes of Siglec-15
  • The regulation and mechanisms of ImKTX58 on KV1.3 channel
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics